Sudden severe vertigo may signal vestibular neuritis — or stroke
Diseasesvestibular neuritis
Signals
Every pharma-relevant, de-duplicated event surfaced so far, primary source first. Client-scoped signals are never shown here.
Handok wins Korean approval for Vonjo in myelofibrosis with severe thrombocytopenia
CompaniesHandokAssetsVonjo Capsulepacritinib citrateDiseasesmyelofibrosismyeloproliferative neoplasmsevere thrombocytopenia
EuBiologics H1 sales, profit fall from high base after 2025 cholera vaccine surge
CompaniesEuBiologics
PanGen Biotech Q2 sales rise 13.5% on EPO exports, but costs push it into loss
CompaniesPanGen BiotechHuons GroupAssetsEPO
Noul gets state backing to accelerate IVDR transition in Europe
CompaniesNoul
SK bioscience takes Gates-backed RSV antibody into infant trial in South Africa
CompaniesSK bioscienceGates Medical Research InstituteAssetsRSV preventive antibody
Celltrion's Vegzelma tops 10% US market share as new analysis backs comparability
CompaniesCelltrionAssetsVegzelmaAvastin
AI helps specialists better pinpoint genetic causes of retinal diseases
CompaniesSeverance HospitalDiseasesinherited retinal diseases
Korea urged to rethink elderly joint, spine care in super-aged era
AbTis prevails in US patent challenge over ADC platform
CompaniesAbTisDong-A STAjinomotoAssetsAbClick ADC conjugation platform
GC Genome's operating profit jumps 120% as core diagnostics grow
CompaniesGC Genome
Pfizer's Abrysvo wins Korean approval for maternal and adult RSV prevention
CompaniesPfizer KoreaAssetsAbrysvoDiseasesRSV
Enhertu, Datroway push DXd ADCs across breast cancer treatment landscape
CompaniesDaiichi Sankyo KoreaAstraZenecaAssetsEnhertuDatrowayDiseasesmetastatic breast cancerHER2-low breast cancerHER2-ultralow breast cancerHER2-positive breast cancerHR-positive breast cancer
Related coverage (2) — shares extracted facts, not the same cluster
Irregular periods, unexplained breast milk discharge may signal pituitary tumors
Diseasespituitary tumors
Yuyu Pharma posts 109% jump in Q2 operating profit on sales growth, cost cuts
CompaniesYuyu Pharma
Former Bridge Biotherapeutics CEO Lee resurfaces in biotech after BBT-877 fallout
CompaniesBridge BiotherapeuticsGPCR TherapeuticsAptNHaplnScienceLG ChemCrystal GenomicsLee & Lee Advisory
Humedix posts record Q2 sales on Re2O growth, ophthalmic solution orders
CompaniesHumedixHuons GroupAssetsRe2OElravie Re2O ECM cosmetic productsDermaShine Duo_RF medical deviceArche wound dressingIzmentValpien
BioSolution begins CartiLife commercialization in China with 1st patient treatments
CompaniesBioSolutionAssetsCartiLifeDiseasessymptomatic cartilage defectknee osteoarthritis
Neurophet takes brain AI into corporate health checkup market with Neomark
CompaniesNeurophetNeomark
MEPSGEN gets up to ₩5bil. to scale drug delivery manufacturing platform
CompaniesMEPSGEN